Discovery and Structure-Based Optimization of Fragments Binding the Mixed Lineage Kinase Domain-like Protein Executioner Domain
Martin Rübbelke(Boehringer Ingelheim (Germany)), Markus Zeeb(Boehringer Ingelheim (Germany)), Florian Binder(Boehringer Ingelheim (Germany)), Margit Bauer(Boehringer Ingelheim (Germany)), Jim King(Boehringer Ingelheim (United States)), Herbert Nar(Boehringer Ingelheim (Germany)), James A. Hamilton(Boston University)
Cited by 15
Related Papers
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0
|Journal of Molecular Biology|1991|487
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
|Journal of Medicinal Chemistry|2002|454
Biophysics in drug discovery: impact, challenges and opportunities
|Nature Reviews Drug Discovery|2016|383
Location of High and Low Affinity Fatty Acid Binding Sites on Human Serum Albumin Revealed by NMR Drug-competition Analysis
|Journal of Molecular Biology|2006|343